It is my great pleasure to announce a special issue of Current Pharmaceutical Design will focus on Bone Morphogenetic Proteins for Bone Regeneration and Their Alternatives. This issue summarizes current perspectives on the use of bioactive molecules, as well as evaluating other strategies such as stem cells, biomaterials, vascularization, and gene therapy for bone regenerative engineering. We thank our outstanding contributors for participating, including our colleagues here at the Health Center, Drs. Marja Hurley and Sangamesh Kumbar. In addition, I would like to acknowledge the efforts of guest editor Dr. Kevin Lo, a faculty member here in the Institute for Regenerative Engineering. Without his time and effort, this issue would not have been possible.

The Special Issue has been published electronically by Bentham Science Publishers. The print version will be available very soon.

---